Abstract:Osteoarthritis (OA) is the most common cause of disability worldwide among the elderly. Alarmingly, the incidence of OA in individuals less than 40 years of age is rising, likely due to the increase in obesity and post-traumatic osteoarthritis (PTOA). In recent years, due to a better understanding of the underlying pathophysiology of OA, several potential therapeutic approaches targeting specific molecular pathways have been identified. In particular, the role of inflammation and the immune system has been increasingly recognized as important in a variety of musculoskeletal diseases, including OA. Similarly, higher levels of host cellular senescence, characterized by cessation of cell division and the secretion of a senescence-associated secretory phenotype (SASP) within the local tissue microenvironments, have also been linked to OA and its progression. New advances in the field, including stem cell therapies and senolytics, are emerging with the goal of slowing disease progression. Mesenchymal stem/stromal cells (MSCs) are a subset of multipotent adult stem cells that have demonstrated the potential to modulate unchecked inflammation, reverse fibrosis, attenuate pain, and potentially treat patients with OA. Numerous studies have demonstrated the potential of MSC extracellular vesicles (EVs) as cell-free treatments that comply with FDA regulations. EVs, including exosomes and microvesicles, are released by numerous cell types and are increasingly recognized as playing a critical role in cell–cell communication in age-related diseases, including OA. Treatment strategies for OA are being developed that target senescent cells and the paracrine and autocrine secretions of SASP. This article highlights the encouraging potential for MSC or MSC-derived products alone or in combination with senolytics to control patient symptoms and potentially mitigate the progression of OA. We will also explore the application of genomic principles to the study of OA and the potential for the discovery of OA phenotypes that can motivate more precise patient-driven treatments.

Mechanisms and therapeutic implications of cellular senescence in osteoarthritis

Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications

Aging, Cell Senescence, the Pathogenesis and Targeted Therapies of Osteoarthritis

Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis

Cellular Aging, Senescence and Autophagy Processes in Osteoarthritis

Senescence in osteoarthritis: from mechanism to potential treatment

Therapeutic Perspectives for Inflammation and Senescence in Osteoarthritis Using Mesenchymal Stem Cells, Mesenchymal Stem Cell-Derived Extracellular Vesicles and Senolytic Agents

Advances in targeted therapies for age-related osteoarthritis: A comprehensive review of current research

Research Progress of Cellular Senescence in the Pathogenesis of Osteoarthritis

Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis

Chondrocyte Aging: The Molecular Determinants and Therapeutic Opportunities

Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging

Cellular Senescence and Inflammaging in the Bone: Pathways, Genetics, Anti-Aging Strategies and Interventions

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

Osteoarthritis: Novel Molecular Mechanisms Increase Our Understanding of the Disease Pathology

Mechanical stress abnormalities promote chondrocyte senescence - The pathogenesis of knee osteoarthritis

Inflammatory and Metabolic Signaling Interfaces of the Hypertrophic and Senescent Chondrocyte Phenotypes Associated with Osteoarthritis

Cellular Senescence: The Driving Force of Musculoskeletal Diseases

Mechanisms of chondrocyte cell death in osteoarthritis: implications for disease progression and treatment

Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics

Age Related Osteoarthritis: Regenerative Therapy, Synthetic Drugs, and Naturopathy to Combat Abnormal Signal Transduction